Covid cases surge in Singapore and Hong Kong: Key symptoms of LF.7 and NB.1.8 variants
COVID-19 cases are rising sharply across parts of Asia, particularly in Singapore and Hong Kong. The latest surge is being driven by two fast-spreading subvariants—LF.7 and NB.1.8—both of which are descendants of the JN.1 lineage, itself a subvariant of the Omicron strain.
The World Health Organization (WHO) has classified JN.1 as a 'variant of interest' due to its rapid transmission, though it has not been labeled a 'variant of concern.' Its descendants, LF.7 and NB.1.8, are now under global observation.
What's driving the spike?
The sharp increase in cases is primarily linked to increased transmissibility of these subvariants and waning immunity in the population.
According to Singapore's Ministry of Health, 'At present, LF.7 and NB.1.8 (both descendants of the JN.1 variant) are the main COVID-19 variants circulating in Singapore, together accounting for more than two-thirds of locally sequenced cases.'
This shift in variant dominance has led to a 28% rise in infections in Singapore during the week ending May 3, 2025. Similarly, Hong Kong has observed a significant increase in cases, with COVID-19 test positivity jumping from 6.21% to 13.66% over a four-week period, indicating rapid spread of these variants.
Experts say the rise is also influenced by reduced protection from prior infections or vaccinations, increased social mixing, and relaxed preventive behavior.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Médicos alertam: se você tem varizes, faça isso todos os dias
Fim das Varizes
Undo
Seasonal effects may also play a role in amplifying transmission during certain periods.
Symptoms
So far, the symptoms linked to LF.7 and NB.1.8 remain consistent with other Omicron subvariants. These include:
Sore throat
Mild cough
Fatigue
Fever
Health authorities across the region report that most cases remain mild, especially among vaccinated individuals. However, older adults and those with underlying health conditions remain more vulnerable to complications.
An official from India, which is currently monitoring 257 cases, noted: 'As per the preliminary information available, the cases are mostly mild, not associated with unusual severity or mortality.'
As per Dr. Diksha Goyal, Senior Consultant at Internal Medicine Marengo Asia Hospitals Gurugram, the symptoms of LF.7 include- "fever, headache, body aches, fatigue, and occasionally gastrointestinal symptoms in the form of nausea or vomiting."
Further, she added, "Respiratory symptoms of cough and dyspnea may be present in certain instances. The severity can also depend on the immunity and conditions of the patient.
"
"NB.1.8 will usually have mild to moderately severe respiratory symptoms such as sore throat, rhinitis, cough, and mild fever intermittently. Some will also present with fatigue, muscular aches, or a mild headache," said Dr Diksha. She also explained that while the symptoms are similar to a typical common cold but "can have variable severity by age, immunity, and comorbidities."
Vaccine protection and WHO classification
Vaccines—particularly booster doses designed against Omicron—continue to offer strong protection against severe disease and death. However, preliminary data suggests LF.7 and NB.1.8 may partially reduce the efficacy of existing vaccines, leading to more breakthrough infections.
This has prompted health experts to consider updating vaccine formulations in the months ahead.
As of May 2025, the WHO has not classified LF.7 or NB.1.8 as Variants of Concern (VOC) or Variants of Interest (VOI). Instead, they are designated as Variants Under Monitoring (VUM). This status indicates that, while they do not currently pose a global health threat, they are being closely observed for their potential to affect transmission dynamics or vaccine effectiveness.
(Images are for representational purpose only)
One step to a healthier you—join Times Health+ Yoga and feel the change
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
16 minutes ago
- New Indian Express
35-year-old man with comorbidities dies ten days after testing positive for COVID-19
VILLUPURAM: A 35-year-old man passed away ten days after testing positive for COVID-19 at the Villupuram government medical college hospital on June 6. The deceased, identified as Thiagarajan, a native of Perapperi village near Tindivanam, had been working as a construction contractor in Hyderabad. He allegedly contracted the virus while at work in Hyderabad ten days ago. Following the onset of fever and other COVID-related symptoms, he returned to his native village in Tindivanam, a week ago. Initially admitted to the Tindivanam government hospital, Thiagarajan was later referred to the Villupuram government medical college hospital for advanced treatment after his condition worsened early on June 6. Despite intensive medical efforts, he passed away due to cardiac failure, medical sources said. The deceased was diabetic, suffered from hypertension, cardiac issues and was under medication for Tuberculosis. Further, sources stated that his health deteriorated rapidly after his return from Hyderabad, leading to his eventual demise. Speaking to TNIE, Villupuram Deputy Director Health Services Dr Senthil Kumar said, "The patient tested positive for COVID in Hyderabad. However, he tested negative on Friday morning, but he died due to comorbidities. Six members who were in contact with him were isolated. People in the village have been asked to follow COVID-19 safety guidelines."
India Today
33 minutes ago
- India Today
New coronavirus in China shows pandemic-like threat, scientists warn
A group of mysterious bat viruses might be just one tiny mutation away from becoming a serious problem for humans, warn US researchers in a new study published in the peer-reviewed journal Nature viruses belong to the same family as MERS-CoV, a dangerous coronavirus that emerged in 2012 and causes severe respiratory a death rate of around 34%, MERS-CoV has already shown the world what these viruses are capable Now, scientists from Washington State University, Caltech, and the University of North Carolina have turned their focus to a lesser-known subgroup called these, one subgroup in particular, called the HKU5 viruses, is raising red flags."HKU5 viruses haven't been studied much, but our research shows they have the machinery to infect cells. In fact, they might be only a single step away from being able to infect humans,' said Dr. Michael Letko, a virologist and lead author of the IS THIS WORRYING?Like the SARS-CoV-2 virus that causes Covid-19, these bat viruses use a spike protein to latch onto cells and infect them. With a death rate of around 34%, MERS-CoV has already shown the world what these viruses are capable of. () advertisementThis study showed that HKU5 viruses can bind to a receptor called ACE2, the same one used by Covid-19, but currently only in bats, not that line is thinner than it just a small genetic tweak, these viruses could potentially start binding to human cells. In fact, some versions have already been spotted infecting minks in China, a sign that they can jump across if that mutation happens in just the right way, the next big spillover could be on the horizon."These viruses are very close relatives of MERS. That alone should make us pay attention," Letko said in a take the research a step further, scientists also used AI, specifically a tool called AlphaFold 3, to simulate how the spike protein would interact with ACE2 receptors. This study showed that HKU5 viruses can bind to a receptor called ACE2, the same one used by Covid-19, but currently only in bats, not humans.() This software predicted virus behaviour in minutes, a process that would usually take months of lab work. The AI's findings closely matched results from traditional lab researchers had earlier shared findings of the new bat coronavirus, HKU5-CoV-2 in study led by virologist Shi Zhengli, who is also known as the 'batwoman".Zhengli found that in lab experiments, HKU5-CoV-2 infected human cells with high ACE2 levels in test tubes and in models of human intestines and researchers also identified monoclonal antibodies and antiviral drugs that target the bat DOES THIS STUDY MATTER?The study's findings matter because, as we've learned from Covid-19, viruses don't need a passport to go global. If we ignore the warning signs, we risk another pandemic blindsiding an eye on viruses like HKU5 gives scientists a head start in developing vaccines, treatments, and public health strategies, before it's too Dr. Letko put it, there's no need to panic, but there is every reason to prepare.
Time of India
37 minutes ago
- Time of India
WHO DG holds talks with PM's Secy on partnership at Global Traditional Medicine Centre
Geneva: Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus on Thursday (local time) held talks with PK Mishra , Principal Secretary to Prime Minister where they discussed their partnership on the WHO Global Traditional Medicine Centre , outposted in Jamnagar . Ghebreyesus thanked Mishra for India's leadership on the Pandemic Accord adoption, and support of increased assessed contributions to WHO's work to advance health for all. "Had good meeting with P.K. Mishra, Principal Secretary to PMO India, on the many areas of close collaboration between WHO and India. We discussed our partnership on the WHO Global Traditional Medicine Centre, outposted in Jamnagar, which will help the world benefit from the potential of traditional medicine and complement modern approaches to health. I thanked Dr Mishra for India's leadership on the Pandemic Accord adoption, and support of increased assessed contributions to WHO's work to advance Health for All. I also commended India for its investment in health care infrastructure, the " Ayushman Bharat " scheme to expand universal health coverage, and in digital health." Mishra also held talks with Hara Hiroaki, Vice-Minister for Policy Coordination of Japan, on margins of Global Platform for Disaster Risk Reduction 2025. In a post on X, the Indian Permanent Mission at Geneva stated, "Fruitful discussions between Principal Secretary to PM Dr. P.K Mishra and Mr. Hara Hiroaki, Vice-Minister for Policy Coordination of Japan, on margins of GPDRR 2025. Explored enhanced India-Japan collaboration on disaster resilience and exchanging expertise in risk reduction strategies." Mishra also held talks on disaster preparedness with Major General Ariunbuyan Gombojav, Chief of National Emergency Management Agency of Mongolia, on the sidelines of GPDRR 2025. "Principal Secretary to PM Dr. P.K Mishra meets with Major General Ariunbuyan Gombojav, Chief of National Emergency Management Agency of Mongolia, on the sidelines of GPDRR 2025. Valuable exchange on disaster preparedness strategies and exploring opportunities for India-Mongolia cooperation in DRR." Mishra also held talks with Head of UNDRR Kamal Kishore on strengthening India's disaster risk reduction partnerships and advancing global resilience frameworks. Meanwhile, BIMSTEC countries convened at the High-Level UNDRR-BIMSTEC event on the margins of GPDRR 2025 in Geneva. India's head of delegation to GPDRR, Principal Secretary to PM PK Mishra, highlighted the role of the BIMSTEC Centre for Disaster Management, as announced by PM Narendra Modi at the 6th BIMSTEC Summit, to accelerate the region's implementation of the Sendai Framework.
